Joyher pro
Joyher pro has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Jun 10, 2026: “A self-care smartphone application for midlife women with menopausal symptoms: A proof-of-concept study”.
1 paper studies it1 findingUpdated
See all 1 papers on joyher pro
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“The total sQACS score significantly decreased from baseline to three and six months (both p < 0.001).”
Humans: a single group. Cells, worms or flies and mice: nothing yet.
- 1 lab in 1 country
- Funders: Ministry of Economy, Trade and Industry and 1 more
- 1 of 1 finding with company ties
- Human trial1
Studies in people
1 study gave joyher pro to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases menopausal symptomsp < 0.001 | Trialsix months | 91 peopleWomen45-55 yearsMidlife adults; Postmenopausal women; moderate menopausal symptoms | Digital health, Jun 10, 2026 |
What did studies of joyher pro find?
1Studies of joyher pro measured one outcome, menopausal symptoms.
Menopausal symptoms
downin humans1
1 study
Menopausal symptoms
downin humans1
Joyher pro decreases menopausal symptoms in humans (moderate menopausal symptoms) (p < 0.001).
“The total sQACS score significantly decreased from baseline to three and six months (both p < 0.001).”
Human trialmoderate menopausal symptomssix monthsfemalesn = 91
Digital health
Latest
1 paper in 12 monthsDigital Health
A self-care smartphone application for midlife women with menopausal symptoms: A proof-of-concept study
Non-randomized trial in 91 peopleClimacteric symptoms